Elyxium Wealth’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.52M Buy
1,652
+132
+9% +$134K 0.49% 51
2025
Q4
$1.63M Buy
1,520
+25
+2% +$23.9K 0.45% 46
2025
Q3
$1.14M Sell
1,495
-337
-18% -$251K 0.4% 55
2025
Q2
$1.43M Buy
1,832
+122
+7% +$94.8K 0.54% 45
2025
Q1
$1.41M Buy
1,710
+1,177
+221% +$979K 0.63% 39
2024
Q4
$411K Sell
533
-752
-59% -$623K 0.25% 57
2024
Q3
$1.14M Buy
+1,285
New +$1.16M 0.63% 38

Other funds holding LLY

Elyxium Wealth's LLY Position: Q1 2026 in Review

Elyxium Wealth increased its Eli Lilly (LLY) stake by 8.7% in Q1 2026, buying an estimated $134K and bringing the position to 1,652 shares worth $1.52M. The position accounts for 0.49% of the portfolio, ranked #51.

Elyxium Wealth first reported a position in LLY in Q3 2024 and has held it in 7 quarters since. The position peaked at $1.63M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Elyxium Wealth held 1,652 shares of Eli Lilly worth $1.52M as of Q1 2026.
  • Elyxium Wealth bought 132 Eli Lilly shares in Q1 2026, an estimated $134K.
  • Eli Lilly made up 0.49% of Elyxium Wealth's portfolio in Q1 2026, its #51 holding.
  • Elyxium Wealth first reported a position in Eli Lilly in Q3 2024 and has held it in 7 quarters since.
  • Elyxium Wealth's Eli Lilly position peaked at $1.63M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Elyxium Wealth's 13F filing for Q1 2026, filed 6 May 2026.